Fabrinet vs Taskus Inc — how do they compare? Fabrinet trades at $466.17 (market cap $17.44B), while Taskus Inc trades at $6.06 (market cap $547.18M). The key difference: Fabrinet is far larger — about 31.9× Taskus Inc's market cap, and Fabrinet is trading nearer its 52-week high, Taskus Inc nearer its low. Which is the better fit depends on your goals.
| FN | TASK | |
|---|---|---|
Market Cap | $17.44B | $547.18M |
Sector | Technology | Technology |
52-Week High | $746.47 | $18.21 |
52-Week Low | $277.04 | $4.57 |
Enterprise Value | $16.50B | $942.88M |
Signals from Pluang's Aura AI — not financial advice
Fabrinet (FN) trades at $474.19, down 1.78% on the day, with a bearish technical signal despite strong fundamental performance. The stock has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.72 exceeding expectations. Analyst consensus remains strongly bullish with a $733 price target, though technical indicators show selling pressure with support at $473 and resistance at $484.
FN presents a compelling growth story driven by AI infrastructure demand, with revenue projected to grow from $3.42B to $4.2B in 2026. However, premium valuation metrics (P/E 41.81, P/B 7.57) and technical bearishness create near-term headwinds. The risk-reward favors long-term investors given the company's strategic positioning in optical communications and debt-free balance sheet.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Fabrinet provides advanced optical and electromechanical manufacturing services to original equipment manufacturers. It specializes in complex products for telecom, automotive, and medical industries.
Read more on FN →TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to innovative and disruptive technology companies. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
Read more on TASK →